Regulatory Filings • Dec 24, 2025
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
| �������� ��������� ��"� | 2 381 |
| ENLIVEX THERAPEUTICS LTD | |
| Corporation no: 514716489 | 12568 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 23/12/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-102711 | Time of broadcast: 23:47 23:47 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | FROM F-3 |
3F23122025_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/08/2024 |
| Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070 | |
| E-mail address: [email protected] Company site: www.enlivex.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R | |
| Address: Einstein 14 , nez ziona 7403618 Telephone: 02-6208072 Facsimile: E-mail: [email protected] 1 | |
| ISRAEL |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.